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In right-side out rat hepatic canalicular membrane vesicles glutathione disulfide (GSSG) inhibited the efflux 
of tdurocholate approx. 70% in the presence or approx. 55% in the absence of a valinomycin-mediated K+ 
diffusion potential; maximal inhibition occurred at 5 mM GSSG. The inhibition by GSSG was abolished 
by dithioerythritol. Neither dithioerythritol alone nor GSH inhibited taurocholate efflux. S-(2,CDinitro- 
phenyl)glutathione and N-ethylmaleimide showed intermediate inhibitory effects. 
Taurocholate transport; Glutathione disulfide; (Rat canalicular membrane vesicle) 
1. INTRODUCTION 
The hepatic clearance of bile acids depends upon 
transport across both basolateral and canalicular 
membranes. Efflux from the hepatocyte into the 
bile duct, i.e. the canalicular pole, is the rate- 
limiting step [ 11. The in vivo excretion of bile acids 
can be mimicked by the efflux of taurocholate 
from isolated right-side out canalicular membrane 
vesicles [2,3]. Efflux is mediated by a 
Na+-independent anion carrier and appears to be 
driven by the physiologic intracellular negative 
membrane potential of approx. - 30 to - 40 mV 
]2,31. 
Previous work has shown that glutathione 
disulfide (GSSG) is specifically excreted into the 
bile [4]. In the perfused rat liver, thiol oxidants or 
hydroperoxides were able to inhibit the excretion 
of taurocholate leaving hepatic uptake of 
taurocholate unaffected [5]. Evidence was 
presented that the inhibition was not due to the 
thiol oxidants themselves but to the formation of 
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intracellular GSSG [5]. In this study, we have in- 
vestigated the influence of GSSG and related com- 
pounds on taurocholate transport using isolated 
right-side out canalicular membrane vesicles. 
2. MATERIALS AND METHODS 
2.1. Preparation of rat hepatic canalicular 
membrane vesicles 
Canalicular membrane vesicles were isolated 
from 8 to 10 male Wistar rat livers using a com- 
bination of rate zonal flotation and high speed cen- 
trifugation through a discontinuous sucrose 
gradient as described by Meier et al. [3,6]. At the 
conclusion of the various centrifugation steps, the 
canalicular membrane pellet was resuspended in a 
medium consisting of 100 mM sucrose, 0.2 mM 
Ca gluconate, 5 mM Mg gluconate, 100 mM K 
gluconate and 20 mM Hepes (pH 7.5). To generate 
a K+-mediated iffusion potential, the K gluconate 
was replaced with tetramethylammonium 
gluconate (100 mM). 
The enrichment relative to the liver homogenate 
(spec. act.) in the canalicular membrane prepara- 
tion was measured for the following marker en- 
zymes: Mg’+-ATPase [7], 126-fold (1.8 + 
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0.2 U/mg protein); alkaline phosphatase [8], 
48-fold (0.2 + 0.01 U/mg protein); y- 
glutamyltranspeptidase [9], 11Cfold (25.1 f 
3.2 U/mg protein). The presence of contaminants 
was ascertained by measuring: NADPH- 
cytochrome c reductase [lo], O.O&fold (1.4 f 
0.4 U/mg protein); succinate cytochrome c reduc- 
tase [11,12], 0.52-fold (3.3 + 1.7 mU/mg protein); 
acid phosphatase [8], 1.86-fold (10.8 + 
1.3 mU/mg protein). Isolated canalicular mem- 
brane vesicles contained no measurable Na,K- 
ATPase [7] activity. Protein was measured by the 
method of Lowry et al. [ 131 using bovine serum 
albumin as a standard. Electron micrographs of 
the isolated canalicular membrane vesicles revealed 
a pure variable-sized population of membrane 
vesicles, virtually free of desmosomes, ribosomes 
and gap junctions, comparable to previous results 
reported by Meier et al. [6]. 
2.2. Transport studies 
Transmembrane transport of [3H]taurocholate 
was measured by a rapid filtration technique as in 
[6]. The vesicles were preloaded and revesiculated 
in the presence of 10 pM taurocholate and valino- 
mycin (10 pg/mg protein). Efflux was started by 
the addition of 180 ~1 of incubation medium to 
20 pl of preloaded membrane vesicles. Transport 
was terminated by the addition of 3 ml of ice-cold 
medium and subsequent rapid filtration was car- 
ried out through a 0.45 pm cellulose nitrate filter 
(Type SM11306, Sartorius GmbH, Gottingen, 
FRG), prefiltered with 1 ml of cold 1 mM tauro- 
cholate to diminish nonspecific filter binding. The 
filter was washed twice with 3.0 ml of the ice-cold 
medium and counted in a liquid scintillation 
counter. All incubations were performed in 
triplicate within one experiment. 
2.3. Materials 
GSSG, reduced glutathione (GSH), and ouabain 
were obtained from Boehringer (Mannheim, 
FRG); taurocholic acid, valinomycin, dithio- 
erythritol, tetramethylammonium hydroxide and 
the gluconates from Sigma (St. Louis, MO); 
sucrose, gluconic acid lactone and N-ethylmale- 
imide from Merck (Darmstadt, FRG). All other 
chemicals and reagents (analytical grade) were pur- 
chased from either Sigma, Merck, Boehringer or 
Serva (Heidelberg, FRG). [3H]Taurocholate 
(6.8 Ci/mmol) was obtained from NEN (Dreieich, 
FRG). A glutathione conjugate of l-chloro-2,4- 
dinitrobenzene, S-(2,4-dinitrophenyl)glutathione 
was prepared according to the procedure of 
Awasthi et al. [ 141. 
3. RESULTS 
3.1. Inhibition of taurocholate effrwr from 
canalicular membrane vesicles by the addition 
of GSSG 
Taurocholate efflux from canalicular membrane 
vesicles can be stimulated by an artificially induced 
valinomycin-mediated K+ diffusion potential (in- 
side negative) indicating a potential-sensitive con- 
ductive pathway for the canalicular excretion of 
taurocholate ([6], see fig.1). Within the first 30 s, 
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Fig. 1. Taurocholate fflux from canalicular membrane 
vesicles. Transport studies were carried out at 2YC in 
the presence (m , 0) and absence (o,o) of a K+ 
diffusion potential (see section 2.3). Control (m ,o) and 
5 mM GSSG added (0 ,O). The transport studies were 
also performed at 0°C (---). Equilibrium (60 min) 
values (as pmol/mg protein) were statistically 
equivalent. At 25°C it was 60.6 f 2.6 and at 2’C, 8.5 f 
0.9; means f SE (n = 4-6, except he 30 s time point, 
n = 15-25). 
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there is a rapid and linear transport phase which 
then levels off. The addition of 5 mM GSSG, 
placed both intra- and extravesicularly, inhibits the 
efflux of taurocholate to the same level in both 
non-gradient and imposed valinomycin-mediated 
K+ gradient conditions. In the case of the imposed 
gradient, the inhibition amounted to 70%. The ac- 
tivities are temperature-sensitive as transport is 
limited to very low levels at 2°C (fig.1). 
3.2. Concentration dependence of GSSG on 
taurocholate effiux 
Significant inhibition of taurocholate efflux by 
GSSG is seen at concentrations above 1 mM (cf. 
[ 151) while the maximal inhibition of taurocholate 
efflux is reached at concentrations of 5 mM GSSG 
(fig.2; see fig.1, 30 s time point). The extent of in- 
hibition is independent of the preincubation with 
the disulfide on ice. Starting the efflux 0, 5 and 
30 min after preloading and vesiculation with 
taurocholate and GSSG had no influence on the 
transport activities and the concentration 
dependence of inhibition (fig.2). 
0-L I I 
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Fig.2. Concentration dependence of GSSG on 
taurocholate efflux from canalicular membrane vesicles. 
30 s transports in the absence of a K+ gradient were run 
at 25”C, following preincubation at 2°C for 0 min (0), 
5 min (0) and 30 min (A) prior to the initiation of 
transport; means f SE (n = 4-6). 
Table 1 
Influence of different forms of glutathione, 
dithioerythritol and N-ethylmaleimide on taurocholate 
efflux from canalicular membrane vesicles 
Additions Taurocholate efflux 
pmol/mg pro- % 
tein per 30 s 
None 
GSSG (5 mM) 
GSSG (5 mM) + dithio- 
23.3 f 2.7 100 
8.3 f 1.0 36 
erythritol (7.5 mM) 24.7 L?Z 2.7 106 
Dithioerythritol (7.5 mM) 22.1 f 2.6 95 
S-(2,4-DinitrophenyQglutathione 
(5 mM) 13.4 k 3.2 58 
GSH (5 mM) 24.7 f 3.0 106 
N-Ethylmaleimide (250 PM) 12.9 f 3.0 55 
Values represent ransport rates during the first 30 s in 
the absence of a K+ diffusion potential; means + SE 
(n = 4) 
3.3. Specificity of GSSG inhibition on 
taurocholate efflux 
The inhibitory effects on taurocholate efflux of 
several compounds are presented in table 1. The 
addition of 7.5 mM dithioerythritol to the 5 mM 
GSSG was sufficient to abolish the inhibition by 
GSSG. Dithioerythritol alone did not influence the 
efflux of taurocholate. 9(2,6Dinitrophenyl)- 
glutathione, at a concentration of 5 mM, showed 
intermediate inhibitory effects, whereas the addi- 
tion of 5 mM reduced glutathione showed no in- 
hibition compared to the control. The thiol- 
binding reagent, N-ethylmaleimide, at 250 PM, 
showed a partial inhibition indicating a possible in- 
volvement of protein -SH in the transport 
mechanism. 
4. DISCUSSION 
The use of photoaffinity probes substantiate 
distinct bile acid binding polypeptides in 
basolateral (54 and 48 kDa) and canalicular 
(100 kDa) membrane subfractions [16]. Inoue et 
al. [2] examined the transport of taurocholate 
from the luminal side into rat canalicular mem- 
brane vesicles and demonstrated a temperature- 
dependent, Na+-independent transport which 
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followed saturation kinetics (approximate K, for 
taurocholate = 43 PM and a V,,,, = 0.22 nmol/mg 
protein per 20 s at 37°C) and was inhibited by 
cholate and probenecid. Meier et al. [3] further in- 
vestigated this carrier-mediated transport of 
taurocholate by measuring its efflux from right- 
side out rat canalicular membrane vesicles. In the 
isolated perfused rat liver, GSSG efflux occurs into 
the bile and was substantially increased with 
hydroperoxides or HzOz-generating compounds 
[4] and stimulation of GSSG formation inhibited 
the biliary excretion of taurocholate, leaving the 
net hepatic uptake from the sinusoidal compart- 
ment unaffected [5]. Using isolated canalicular 
membrane vesicles, Akerboom et al. [17] 
demonstrated that the transport of GSSG across 
the canalicular membrane though outside-to- 
inside, is also a carrier-mediated process. The 
findings presented in the present paper 
demonstrate that GSSG inhibits the efflux of 
taurocholate from canalicular membrane vesicles 
(fig. 1). It is of interest hat GSSG (5 mM) inhibited 
taurocholate efflux to similar rates in both non-K+ 
gradient and imposed K+ gradient conditions. 
During maximal inhibition by GSSG the transport 
rate was still substantially above the transport rate 
observed on ice. 
Fig.1 also shows that the maximal separation 
between the control and the GSSG-inhibited 
transport occurred at 30 s, a time point utilized for 
the examination of the concentration dependence 
of GSSG on taurocholate efflux. The inhibition of 
taurocholate transport at 30 s was the maximum 
observed (fig.2). There was no effect of preincuba- 
tion on ice on the concentration dependence of 
taurocholate efflux (fig.2). 
The addition of dithioerythritol to the GSSG 
prior to its addition to the vesicles and transport 
media counteracted the inhibitory effect of GSSG 
(table 1). Dithioerythritol alone, as well as reduced 
glutathione, had no effect on the transport rate. 
Taken together, these observations allow the con- 
clusion that the disulfide configuration is required 
for inhibition. The glutathione conjugate, S- 
(2,4-dinitrophenyl)-glutathione, showed interme- 
diate inhibitory effects. It has been postulated that 
GSSG behaves like a ‘glutathione S-conjugate of 
glutathione’; a homoconjugate handled in a 
similar way to the heteroconjugates [18]. Partial 
inhibition also was observed with the thiol-binding 
reagent, N-ethylmaleimide, indicating a possible 
involvement of protein -SH groups in the 
mechanism of taurocholate efflux. In conclusion, 
this work lends support to the hypothesis 
generated from the isolated perfused rat liver 
studies [5] that GSSG inhibits taurocholate 
transport across the canalicular membrane of the 
hepatocyte. 
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